Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-09-19

Clinical Trial Update: Does Potassium Iodide (SSKI) Reduce Vascularity in Graves' Thyroidectomy? [Phase 3]

View source ↗

Summary

A Phase 3 trial investigated whether potassium iodide (SSKI) can reduce vascularity in Graves' thyroidectomy; the study was terminated and results have been pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Potassium iodide (SSKI) (potassium iodide)

Snippet

Sponsor: Columbia University | Conditions: Graves Disease | Phase 3 | Status: TERMINATED | Results posted: 2024-09-19